Vermont Sen. Bernie Sanders Calls on Moderna to Raise Price of Its COVID-19 Vaccine

“You are proposing to make the vaccine unaffordable for the citizens of this country who made it possible to produce the vaccine,” wrote Sanders, who is expected to become the Senate president of health, education, hard work and pensions later this month. unacceptable. “

Bancel told the Wall Street Journal on Monday that Moderna plans to tax $110 to $130 according to the vaccine dose once the U. S. UU. se move to an injection market.

MODERNA’S OMICRON VACCINE SHOWS BETTER IMMUNE RESPONSE THAN COVID PHOTOS

The steady increase in that diversity is about 8 times the value of early U. S. contracts. The U. S. Food and Drug Administration for the vaccine and nearly five times or so $27 depending on the dose the government paid for boosters last year.

Moderna responded to a request for comment.

Sanders is a Democratic socialist whose presidential campaigns have carried the U. S. Democratic Party’s timeline. U. S. to the left. The Vermont senator has spoken out against drug caps and supported Medicare for All, and his chair of the HELP committee could simply put pharmaceutical corporations in his crosshairs.

CDC DIRECTOR BACKS PHOTOGRAPHS OF MODERNA’S COVID-19 VACCINE

Sanders wrote that Bancel and several of Moderna’s founders became billionaires after the vaccine’s launch. He said the new higher charges would charge U. S. taxpayers billions of dollars and make injections too expensive for uninsured or underinsured Americans.

“Now, in the midst of an ongoing public fitness crisis and a developing federal deficit, now is the time for Moderna to quadruple the value of this vaccine. This is the time for unacceptable corporate greed,” Sanders wrote.

CLICK HERE TO GET THE FOX NEWS APP

Sales of Moderna’s COVID-19 vaccine were approximately $18. 4 billion in 2022. This is expected to fall sharply next year, even with value increases, as demand for vaccines has plummeted. The drugmaker said Monday it expects a minimum of $5 billion in profits from vaccines. This year.

Leave a Comment

Your email address will not be published. Required fields are marked *